Immunotherapy Combined with Radiation in Malignant Melanoma without BRAF Mutations Brain Metastases—Favorable Response after Immunotherapy Continued beyond Progression

Immunotherapy Combined with Radiation in Malignant Melanoma without BRAF Mutations Brain Metastases—Favorable Response after Immunotherapy Continued beyond Progression

We present the case of a patient who was diagnosed in 2018 with nodular Malignant Melanoma (MM) without BRAF V 600 mutations stage 3 C (pT4b pN1a M0), and who underwent adjuvant citokines treatment with Interferon alpha 2b-48 weeks. Immunotherapy was initiated in January 2021 for lung and lymph node...

Full description

Bibliographic Details
Main Authors: Roxana-Andreea Rahnea-Nita, Laura-Florentina Rebegea, Radu-Valeriu Toma, Horia Mocanu, Ioana Soare, Raul Mihailov, Alexandru Nechifor, Mădălin Guliciuc, Georgiana Bianca Constantin, Gabriela Rahnea-Nita
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Journal of Personalized Medicine
Subjects:
malignant melanoma without BRAF V 600 mutations
brain metastases
radiotherapy
immunotherapy beyond progression
favorable response
Online Access:https://www.mdpi.com/2075-4426/14/1/86

Internet

https://www.mdpi.com/2075-4426/14/1/86

Similar Items